Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0CB8D
|
|||
Drug Name |
PMID26924192-Compound-31
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
KYORIN PHARMACEUTICAL CO., LTD
|
|||
Structure |
Download2D MOL |
|||
Formula |
C29H34N6O4
|
|||
Canonical SMILES |
CCOC1=C(C=CC(=C1)C(=O)N2CCC(C2)N3CCCC3)NC4=NC=C5C(=C4)N(C6=C(C(=O)N5C)OC=C6)C
|
|||
InChI |
1S/C29H34N6O4/c1-4-38-25-15-19(28(36)35-13-9-20(18-35)34-11-5-6-12-34)7-8-21(25)31-26-16-23-24(17-30-26)33(3)29(37)27-22(32(23)2)10-14-39-27/h7-8,10,14-17,20H,4-6,9,11-13,18H2,1-3H3,(H,30,31)
|
|||
InChIKey |
MABJPFUJXNIKGP-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Bromodomain-containing protein 4 (BRD4) | Target Info | Inhibitor | [1] |
Target's Patent Info | Bromodomain-containing protein 4 (BRD4) | Target's Patent Info | [1] | |
WikiPathways | Chemical Compounds to monitor Proteins |
References | Top | |||
---|---|---|---|---|
REF 1 | BET inhibitors in cancer therapeutics: a patent review.Expert Opin Ther Pat. 2016;26(4):505-22. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.